SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024687
Filing Date
2020-05-12
Accepted
2020-05-12 16:31:39
Documents
76
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20200331.htm   iXBRL 10-Q 2139691
2 EX-31.1 adpt-ex311_204.htm EX-31.1 24787
3 EX-31.2 adpt-ex312_205.htm EX-31.2 26196
4 EX-32.1 adpt-ex321_203.htm EX-32.1 11623
5 EX-32.2 adpt-ex322_202.htm EX-32.2 13077
  Complete submission text file 0001564590-20-024687.txt   8305131

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adpt-20200331.xsd EX-101.SCH 56265
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20200331_cal.xml EX-101.CAL 55330
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20200331_def.xml EX-101.DEF 201703
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20200331_lab.xml EX-101.LAB 435636
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20200331_pre.xml EX-101.PRE 357462
14 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20200331_htm.xml XML 1653545
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 20869518
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences